Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome von Krogsgaard, L. R., Lyngesen, M., Bytzer, P.

Volltext

Randomised clinical trial: addition of alginate‐antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms von Coyle, C., Crawford, G., Wilkinson, J., Thomas, S. J., Bytzer, P.

Volltext

Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add‐on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor von Reimer, C., Lødrup, A. B., Smith, G., Wilkinson, J., Bytzer, P.

Volltext

Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study von Dent, John, Vakil, Nimish, Jones, Roger, Bytzer, Peter, Schöning, Uwe, Halling, Katarina, Junghard, Ola, Lind, Tore

Volltext

Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification von Engsbro, A. L., Simren, M., Bytzer, P.

Volltext

Editorial: refractory GERD—good drug, wrong patients? Authors’ reply von Coyle, C., Bytzer, P.

Volltext

Editorial: alginates for inadequate response to a proton pump inhibitor in gastro‐oesophageal reflux disease – authors’ reply von Reimer, C., Bytzer, P.

Volltext

Letter: add‐on alginate therapy for reflux patients with inadequate response to a once daily proton pump inhibitor – more questions than answers. Authors’ reply von Bytzer, P., Reimer, C.

Volltext

Impact of an information video before colonoscopy on patient satisfaction and anxiety - a randomized trial von Bytzer, P., Lindeberg, B.

Volltext

Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome—getting the facts right. Authors' reply von Krogsgaard, L. R., Lyngesen, M., Bytzer, P.

Volltext

Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients von Bytzer, P., van Zanten, S. Veldhuyzen, Mattsson, H., Wernersson, B.

Volltext

Assessment of reflux symptom severity: methodological options and their attributes von Bytzer, P

Volltext

Clinical trial: long‐term use of proton pump inhibitors in primary care patients – a cross sectional analysis of 901 patients von REIMER, C., BYTZER, P.

Volltext

The epidemiology of irritable bowel syndrome: Symptom development over a 3‐year period in Denmark. A prospective, population‐based cohort study von Krogsgaard, L. R., Engsbro, A. L., Jones, M. P., Bytzer, P.

Volltext

Use of acid‐suppressive therapy before anti‐reflux surgery in 2922 patients: a nationwide register‐based study in Denmark von Lødrup, A., Pottegård, A., Hallas, J., Bytzer, P.

Volltext

Editorial: anti‐secretory therapy prior to anti‐reflux surgery. Does dose matter? Authors’ reply von Lødrup, A., Pottegård, A., Hallas, J., Bytzer, P.

Volltext

Clinical trial: the glucagon‐like peptide‐1 analogue ROSE‐010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo‐controlled, double‐blind... von HELLSTRÖM, P. M., HEIN, J., BYTZER, P., BJÖRNSSÖN, E., KRISTENSEN, J., SCHAMBYE, H.

Volltext

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation von Tack, J, Müller-Lissner, S, Bytzer, P, Corinaldesi, R, Chang, L, Viegas, A, Schnekenbuehl, S, Dunger-Baldauf, C, Rueegg, P

Volltext

H2 receptor antagonists and prokinetics in dyspepsia: a critical review von Bytzer, P

Volltext

Irritable bowel syndrome: The burden and unmet needs in Europe von Quigley, E.M.M., Bytzer, P., Jones, R., Mearin, F.

Volltext